Skip to main content

News

Philips RADIQAL Trial
low-dose imaging
05/20/2025
“The ability to reduce radiation exposure without compromising procedural performance is a key priority in interventional cardiology,” said Dr. Javier Escaned, Professor of Cardiology at Hospital Clínico San Carlos and principal investigator.
“The ability to reduce radiation exposure without compromising procedural performance is a key priority in interventional cardiology,” said Dr. Javier Escaned, Professor of Cardiology at Hospital Clínico San Carlos and principal investigator.
“The ability to reduce radiation...
05/20/2025
EP Lab Digest
News
05/19/2025
VeriSight Pro 3D ICE catheter is a pioneering innovation — a miniaturized ultrasound probe embedded at the tip of a thin, steerable catheter, navigated through the vascular system into the heart chambers to deliver high-quality 2D and 3D...
VeriSight Pro 3D ICE catheter is a pioneering innovation — a miniaturized ultrasound probe embedded at the tip of a thin, steerable catheter, navigated through the vascular system into the heart chambers to deliver high-quality 2D and 3D...
VeriSight Pro 3D ICE catheter is...
05/19/2025
EP Lab Digest
News
05/19/2025
ESC Heart Failure Late Breaker: Largest single LifeVest® WCD study of NICM and MI/CAD patients shows high appropriate treatment rates during early period of contemporary GDMT
ESC Heart Failure Late Breaker: Largest single LifeVest® WCD study of NICM and MI/CAD patients shows high appropriate treatment rates during early period of contemporary GDMT
ESC Heart Failure Late Breaker:...
05/19/2025
EP Lab Digest
News
05/15/2025
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing therapeutics for patients with cardiovascular disease, today announced manufacturing and supply chain milestones for its lead drug candidate, tecarfarin, a...
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing therapeutics for patients with cardiovascular disease, today announced manufacturing and supply chain milestones for its lead drug candidate, tecarfarin, a...
Cadrenal Therapeutics, Inc....
05/15/2025
EP Lab Digest
News
05/13/2025
Octagos, the industry leader in AI-powered cardiac remote monitoring, today announced the launch of OctaLink, a new clinical companion mobile app delivering the full power of the Octagos platform in the palm of your hands.
Octagos, the industry leader in AI-powered cardiac remote monitoring, today announced the launch of OctaLink, a new clinical companion mobile app delivering the full power of the Octagos platform in the palm of your hands.
Octagos, the industry leader in...
05/13/2025
EP Lab Digest
Press Release
05/13/2025
The live online symposium will be held September 26-27, 2025. While radiation protection is discussed at other conferences, SIRP is the first program dedicated entirely to radiation safety with a goal of reducing the number of...
The live online symposium will be held September 26-27, 2025. While radiation protection is discussed at other conferences, SIRP is the first program dedicated entirely to radiation safety with a goal of reducing the number of...
The live online symposium will...
05/13/2025
Vascular Disease Management
News
05/12/2025
HeartSciences Inc, an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, announced the appointment of Dr. Girish Nadkarni, MD, Dr. Joshua...
HeartSciences Inc, an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, announced the appointment of Dr. Girish Nadkarni, MD, Dr. Joshua...
HeartSciences Inc, an artificial...
05/12/2025
EP Lab Digest
News
05/12/2025
BridgeBio Pharma, Inc. announced that one rapid-fire abstract and two moderated ePosters on the clinical outcomes and quality of life measures provided by acoramidis in variant transthyretin amyloid cardiomyopathy and one moderated ePoster on...
BridgeBio Pharma, Inc. announced that one rapid-fire abstract and two moderated ePosters on the clinical outcomes and quality of life measures provided by acoramidis in variant transthyretin amyloid cardiomyopathy and one moderated ePoster on...
BridgeBio Pharma, Inc. announced...
05/12/2025
EP Lab Digest
News
05/08/2025
Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies
Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies
Prestigious International Annual...
05/08/2025
EP Lab Digest
News
05/06/2025
First patent significantly advances intellectual property for HeartBeam’s credit card-sized ECG device, bolstering both the defensive and offensive moat around the company’s core technology
First patent significantly advances intellectual property for HeartBeam’s credit card-sized ECG device, bolstering both the defensive and offensive moat around the company’s core technology
First patent significantly...
05/06/2025
EP Lab Digest